Lisanti Capital Growth’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-11,400
| Closed | -$1.83M | – | 143 |
|
|
2020
Q2 | $1.83M | Buy |
11,400
+4,868
| +75% | +$781K | 0.37% | 93 |
|
|
2020
Q1 | $639K | Buy |
+6,532
| New | +$639K | 0.21% | 99 |
|
|
2019
Q1 | – | Sell |
-9,350
| Closed | -$1.02M | – | 129 |
|
|
2018
Q4 | $1.02M | Buy |
9,350
+2,030
| +28% | +$221K | 0.41% | 77 |
|
|
2018
Q3 | $1.18M | Sell |
7,320
-1,420
| -16% | -$229K | 0.41% | 90 |
|
|
2018
Q2 | $1.16M | Sell |
8,740
-22,780
| -72% | -$3.01M | 0.44% | 85 |
|
|
2018
Q1 | $2.34M | Buy |
31,520
+11,215
| +55% | +$831K | 1.13% | 35 |
|
|
2017
Q4 | $1.13M | Buy |
20,305
+9,085
| +81% | +$506K | 0.65% | 70 |
|
|
2017
Q3 | $509K | Buy |
+11,220
| New | +$509K | 0.32% | 98 |
|
|
2016
Q4 | – | Sell |
-5,405
| Closed | -$332K | – | 105 |
|
|
2016
Q3 | $332K | Buy |
+5,405
| New | +$332K | 0.42% | 89 |
|